Medtronic the beneficiary of CMS'(Centers for Medicare & Medicaid Services) first special inpatient payment
This article was originally published in Clinica
Executive Summary
Medtronic's genetically engineered bone graft for spinal fusion is the first device to qualify for Medicare's special inpatient payment for new technology. The payment was initially established in 2000.